Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial

Hoosen Coovadia(University of KwaZulu-Natal), Yvonne Maldonado(Palo Alto University), Dhayendre Moodley(Centre for the AIDS Programme of Research in South Africa), Sheryl Zwerski(National Institutes of Health), Lynda Stranix‐Chibanda(University of Zimbabwe), Vani Chetty(Centre for the AIDS Programme of Research in South Africa), Anthony Mwatha(Fred Hutch Cancer Center), Karim Manji(Muhimbili University of Health and Allied Sciences), Diana Lynn(Fred Hutch Cancer Center), Philippa Musoke(Centers for Disease Control and Prevention), Roderick Kisenge(Muhimbili University of Health and Allied Sciences), Susan H. Eshleman(Johns Hopkins University), Kathleen George(Family Health International 360), Lindiwe Msweli(Centre for the AIDS Programme of Research in South Africa), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), P. Andrew(Family Health International 360), Elizabeth R. Brown(Fred Hutch Cancer Center), Mary Glenn Fowler(Johns Hopkins University), Paul Richardson(Johns Hopkins University), Clemensia Nakabiito(Makerere University), Tsungai Chipato(University of Zimbabwe-University of California San Francisco), Laura Guay(Johns Hopkins University), Wafaie Fawzi(Harvard Global Health Institute)
The Lancet
December 23, 2011
Cited by 142


Related Papers